Featured Research

from universities, journals, and other organizations

Drug Prescribed For Migraines And Seizures Found To Increase Risk Of Kidney Stones

Date:
November 2, 2006
Source:
UT Southwestern Medical Center
Summary:
Topiramate, a drug commonly prescribed to treat seizures and migraine headaches, can increase the propensity of calcium phosphate kidney stones, researchers at UT Southwestern Medical Center have found.

Researchers includng Drs. Khashayar Sakhaee (left), chief of mineral metabolism, and Dion Graybeal have discovered that a drug commonly prescribed to treat seizures and migraine headaches can increase the propensity of calcium phosphate kidney stones.
Credit: Image courtesy of UT Southwestern Medical Center

Topiramate (Topamax), a drug commonly prescribed to treat seizures and migraine headaches, can increase the propensity of calcium phosphate kidney stones, researchers at UT Southwestern Medical Center have found.

A study -- the largest cross-sectional examination of how the long-term use of topiramate affects kidney-stone formation -- appears in the October issue of the American Journal of Kidney Diseases.

Several case reports have described an association between topiramate and the development of kidney stones, but this complication had not been well recognized and physicians have not informed patients about the risk, the UT Southwestern researchers said. More important, the mechanism of stone formation was largely unknown previously.

"The wide-spread and escalating use of topiramate emphasizes the importance of considering the long-term impact of this drug on kidney-stone formation," said Dr. Khashayar Sakhaee, senior author of the study and chief of mineral metabolism at UT Southwestern.

More than 29 million Americans suffer from migraines, with women being affected three times more often than men, according to the National Headache Foundation.

"Topiramate is probably one of the most commonly prescribed and most effective neurological medications right now," said Dr. Dion Graybeal, assistant professor of neurology and an author of the study.

Dr. Graybeal and other researchers at UT Southwestern say the next step is to develop a way to block the development of kidney stones for users.

The study comprised two phases. Thirty-two individuals already being treated with topiramate and 50 normal volunteers were enrolled in a cross-sectional study in which their blood and urine were tested for kidney-stone risk. A short-term study also was conducted in seven individuals to assess stone risk before and three months after taking topiramate. All patients were evaluated at UT Southwestern's General Clinical Research Center.

Researchers found that taking topiramate on a long-term basis, or for about one year, caused systemic metabolic acidosis -- a buildup of excessive acid in the blood -- as a result of the inability of the kidney to excrete acid. Topiramate use also increased the urine pH and lowered urine citrate, an important inhibitor of kidney-stone formation.

"These changes increase the propensity to form calcium phosphate stones," Dr. Sakhaee said.

In the short-term study, urinary calcium and oxalate -- a chemical compound that binds strongly with calcium and is found in most calcium stones -- did not significantly change in people taking topiramate.

Kidney stones are solid deposits that form in the kidneys from substances excreted in the urine. When waste materials in urine do not dissolve completely, microscopic particles begin to form and, over time, grow into kidney stones.

Before this study, the rate of kidney-stone formation with topiramate was reported as 1.5 percent. The low incidence rate may be an underestimation due to the short length of observation and the lack of ongoing kidney-stone surveillance and data collection for this drug, said Dr. Sakhaee, holder of the BeautiControl Cosmetics Inc. Professorship in Mineral Metabolism and Osteoporosis.

"There is a legitimate concern for the occurrence of kidney stones with long-term topiramate treatment," said Dr. Sakhaee said. "Studies are needed to explore optimal measures to prevent kidney-stone formation with topiramate use."

Other UT Southwestern researchers contributing to the study were Dr. Orson Moe, director of the Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, Dr. Naim Maalouf, assistant professor of internal medicine and Dr. Brian J. Welch, a postdoctoral fellow in internal medicine.

The research was supported by the National Institutes of Health.


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

UT Southwestern Medical Center. "Drug Prescribed For Migraines And Seizures Found To Increase Risk Of Kidney Stones." ScienceDaily. ScienceDaily, 2 November 2006. <www.sciencedaily.com/releases/2006/10/061031185357.htm>.
UT Southwestern Medical Center. (2006, November 2). Drug Prescribed For Migraines And Seizures Found To Increase Risk Of Kidney Stones. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2006/10/061031185357.htm
UT Southwestern Medical Center. "Drug Prescribed For Migraines And Seizures Found To Increase Risk Of Kidney Stones." ScienceDaily. www.sciencedaily.com/releases/2006/10/061031185357.htm (accessed September 21, 2014).

Share This



More Health & Medicine News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins